BF Biosciences Limited (PSX:BFBIO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
138.18
-0.02 (-0.01%)
At close: Aug 20, 2026

BF Biosciences Balance Sheet

Millions PKR. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
288.13344.47278.77255.44211.67421.69
Short-Term Investments
62.78--147.391,498848.82
Trading Asset Securities
544.141,16739.01---
Cash & Short-Term Investments
895.051,511317.78402.831,7101,271
Cash Growth
-37.78%375.55%-21.11%-76.44%34.58%139.20%
Accounts Receivable
596.2184.24204.6193.8152.71202.49
Other Receivables
-45.5149.3349.64--
Receivables
596.2229.75253.94143.4567.93230.01
Inventory
2,7341,740893.81852.24406.55356.16
Prepaid Expenses
-5.345.882.28--
Other Current Assets
394.13349.88205.26190.5110.9398.97
Total Current Assets
4,6193,8361,6771,5912,2951,956
Property, Plant & Equipment
4,4824,3064,1754,0702,1351,034
Other Intangible Assets
2.73.980.551.11--
Other Long-Term Assets
77.0111.857.834.834.834.83
Total Assets
9,1818,1595,8605,6674,4352,995

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Accounts Payable
1,622321.12269.06225.38394.28401.74
Accrued Expenses
17.06541.51266.09144.713.826.74
Short-Term Debt
216.0829.36328.7473.39149.35-
Current Portion of Long-Term Debt
340.49328.05292.72356.8857.6516.32
Current Unearned Revenue
130.82134.26150.87135.5999.8641.6
Other Current Liabilities
-269.97121.1567.02--
Total Current Liabilities
2,3271,6241,4291,403714.96466.4
Long-Term Debt
1,1671,3671,5911,7721,537873.06
Long-Term Unearned Revenue
241.05318.37432.6503.73331.33172.67
Long-Term Deferred Tax Liabilities
318.87186.5848.3113.5126.5515.99
Total Liabilities
4,0543,4973,5003,6932,6101,528

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Common Stock
265265190190190190
Additional Paid-In Capital
1,7801,780----
Retained Earnings
3,0822,6172,1701,7841,5021,200
Comprehensive Income & Other
----132.776.27
Shareholders' Equity
5,1274,6622,3601,9741,8251,467
Total Liabilities & Equity
9,1818,1595,8605,6674,4352,995

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Total Debt
1,7241,7252,2122,6031,744889.38
Net Cash (Debt)
-828.77-213.54-1,894-2,200-34.26381.13
Net Cash Growth
------27.32%
Net Cash Per Share
-9.38-2.64-29.91-34.74-0.546.02
Filing Date Shares Outstanding
88.3388.3363.3363.3363.3363.33
Total Common Shares Outstanding
88.3388.3363.3363.3363.3363.33
Working Capital
2,2932,212248.08188.341,5801,489
Book Value Per Share
58.0452.7837.2631.1728.8223.16
Tangible Book Value
5,1244,6582,3591,9731,8251,467
Tangible Book Value Per Share
58.0152.7337.2531.1528.8223.16
Land
-25.3625.3625.36--
Buildings
-993.57236.06214.16--
Machinery
-4,1311,191708.94--
Construction In Progress
332.63133.033,5163,884--